Donor HLA-C Genotype Has a Profound Impact on the Clinical Outcome Following Liver Transplantation
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Late allograft dysfunction is a significant problem following liver transplantation and its pathogenesis is uncertain. HLA-C is the major inhibitory ligand for killer immunoglobulin-like receptors (KIRs) that regulate the cytotoxic activity of natural killer (NK) cells. HLA-C alleles can be allocated into two groups, termed HLA-C1 and HLA-C2, based on their KIR specificity. HLA-C2 interactions are more inhibiting to NK cell activation. We studied the clinical importance of HLA-C genotype in a large liver transplant cohort and found that possession of at least one HLA-C2 allele by the donor allograft was associated with less histological evidence of chronic rejection and graft cirrhosis, a 16.2% reduction in graft loss (p = 0.003) (hazard ratio: 2.7, 95% CI 1.4-5.3) and a 13.6% improvement in patient survival (p = 0.01) (hazard ratio: 1.9, 95% CI 1.1-3.3) at 10 years. Transplantation of an HLA-C2 homozygous allograft led to a particularly striking 26.5% reduction in graft loss (p < 0.001) (hazard ratio: 7.2, 95% CI 2.2-23.0) at 10 years when compared to HLA-C1 homozygous allografts. Donor HLA-C genotype is therefore a major determinant of clinical outcome after liver transplantation and reveals the importance of NK cells in chronic rejection and graft cirrhosis. Modulation of HLA-C and KIR interactions represents an important novel approach to promote long-term graft and patient survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687 · cited 1×
“Thus a primary biological role of inhibitory KIRs is to allow effector cells to sense the presence of ‘self’ major histocompatibility complex (MHC) at the cell surface in order to prevent lysis of healthy cells (14).”
BackgroundMHC class I molecules and kirs in human history, health and survival
Parham, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1570 · Cited by 1,203
Hepatic T cells and liver tolerance
Crispe, I. N. (2003) · Nature Reviews Immunology · doi:10.1038/nri981 · Cited by 661 · cited 1×
“T-cell recognition of allogeneic HLA-peptide complexes is considered to be central to the rejection of vascularized allografts (6) but the lack of association between HLA mismatch and clinical outcome indicates that this is not the dominant pathway for liver allograft loss (7,8).”
BackgroundDoherty, D. G., Norris, S., Madrigal-Estebas, L., McEntee, G., Traynor, O., Hegarty, J. E., & O’Farrelly, C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.2314 · Cited by 350 · cited 1×
“It is noteworthy that NK cells comprise over 40% of lymphoid cells in the liver compared to around 13% in peripheral blood (46), and they have been associated with liver injury in chronic viral hepatitis (47).”
Background
Cited by
The relationship between blood groups and disease
Anstee, D. J. (2010) · Blood · doi:10.1182/blood-2010-01-261859 · Cited by 463
Autoimmune liver disease, autoimmunity and liver transplantation
Carbone, M., & Neuberger, J. M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.09.020 · Cited by 250
Recurrence and rejection in liver transplantation for primary sclerosing cholangitis
Fosby, B. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i1.1 · Cited by 175
Donor-derived cell-free DNA levels predict graft injury in liver transplant recipients
Levitsky, J., Kandpal, M., Guo, K., Kleiboeker, S., Sinha, R., & Abecassis, M. (2022) · American Journal of Transplantation · doi:10.1111/ajt.16835 · Cited by 102
Levitsky, J., Asrani, S. K., Schiano, T., Moss, A., Chavin, K., Miller, C., Guo, K., Zhao, L., Kandpal, M., Bridges, N., et al. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15953 · Cited by 44
Metadata
- Authors
- Hanvesakul, R., Spencer, N., Cook, M., Gunson, B., Hathaway, M., Brown, R., Nightingale, P., Cockwell, P., Hubscher, S. G., Adams, D. H., Moss, P., & Briggs, D.
- Venue
- American Journal of Transplantation
- Publisher
- Elsevier BV
- Published
- 2008-09
- Volume
- 8
- Issue
- 9
- Pages
- 1931-1941
- ISSN
- 1600-6135 (ISSN-L)
- OpenAlex
- W2083805872
- Cited by
- 73
- References
- 4
- FWCI
- 8.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Donor HLA-C Genotype Has a Profound Impact on the Clinical Outcome Following Liver Transplantation. https://app.cochat.ai/papers/10.1111/j.1600-6143.2008.02341.x
- The paper
- Hanvesakul, R., Spencer, N., Cook, M., Gunson, B., Hathaway, M., Brown, R., Nightingale, P., Cockwell, P., Hubscher, S. G., Adams, D. H., Moss, P., & Briggs, D. (2008). Donor HLA-C Genotype Has a Profound Impact on the Clinical Outcome Following Liver Transplantation. American Journal of Transplantation. https://doi.org/10.1111/j.1600-6143.2008.02341.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.